Lenalidomide for aggressive B-cell lymphoma involving the central nervous system?

Am J Hematol. 2011 Nov;86(11):957. doi: 10.1002/ajh.22148.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / pharmacokinetics
  • Antineoplastic Agents / therapeutic use*
  • Central Nervous System Neoplasms / diagnosis
  • Central Nervous System Neoplasms / drug therapy*
  • Central Nervous System Neoplasms / secondary
  • Chromatography, Liquid
  • Humans
  • Lenalidomide
  • Lymphoma, Mantle-Cell / diagnosis
  • Lymphoma, Mantle-Cell / drug therapy*
  • Lymphoma, Mantle-Cell / pathology
  • Magnetic Resonance Imaging
  • Male
  • Orbit / drug effects*
  • Orbit / pathology
  • Tandem Mass Spectrometry
  • Thalidomide / analogs & derivatives*
  • Thalidomide / pharmacokinetics
  • Thalidomide / therapeutic use

Substances

  • Antineoplastic Agents
  • Thalidomide
  • Lenalidomide